CervoMed (CRVO) News Today $10.77 -0.15 (-1.37%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period CervoMed Inc. (NASDAQ:CRVO) Short Interest Up 16.5% in OctoberCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,480,000 shares, an increase of 16.5% from the October 15th total of 1,270,000 shares. Based on an average daily volume of 81,400 shares, the days-to-cover ratio is presently 18.2 days. Currently, 27.7% of the shares of the stock are sold short.November 16 at 6:28 AM | marketbeat.comAnalysts Issue Forecasts for CervoMed FY2024 EarningsCervoMed Inc. (NASDAQ:CRVO - Free Report) - Analysts at Brookline Capital Management dropped their FY2024 EPS estimates for CervoMed in a research report issued on Tuesday, November 12th. Brookline Capital Management analyst T. Bussian now expects that the company will post earnings of ($1.88) peNovember 15 at 7:14 AM | marketbeat.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Zai Lab (ZLAB), NeuroPace (NPCE) and CervoMed (CRVO)November 14 at 12:24 AM | markets.businessinsider.comCervoMed Inc. Reports Increased R&D Expenses Amid Ongoing TrialsNovember 14 at 12:24 AM | markets.businessinsider.comCervoMed Inc.: CervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNovember 12, 2024 | finanznachrichten.deCervoMed Reports Third Quarter 2024 Financial Results and Provides Corporate UpdatesNovember 12, 2024 | globenewswire.comCervoMed Awarded the Prix Galien USA 2024 Prize for Best StartupNovember 8, 2024 | globenewswire.comCervoMed to Participate in Upcoming Investor ConferencesNovember 7, 2024 | globenewswire.comCervoMed announces key takeaways from presentations on neflamapimodNovember 4, 2024 | markets.businessinsider.comCervoMed Announces Key Takeaways from Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)November 4, 2024 | globenewswire.comCervoMed’s Neflamapimod: A Promising Phase 2b Trial for Addressing Dementia with Lewy BodiesNovember 1, 2024 | markets.businessinsider.comCervoMed Inc. (NASDAQ:CRVO) Short Interest UpdateCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totalling 1,270,000 shares, a growth of 7.6% from the September 30th total of 1,180,000 shares. Approximately 23.7% of the company's stock are sold short. Based on an average trading volume of 86,700 shares, the short-interest ratio is presently 14.6 days.November 1, 2024 | marketbeat.comCervoMed (NASDAQ:CRVO) Shares Down 3.1% - Time to Sell?CervoMed (NASDAQ:CRVO) Shares Down 3.1% - Here's What HappenedNovember 1, 2024 | marketbeat.comCervoMed to present at International Lewy Body Dementia ConferenceOctober 30, 2024 | markets.businessinsider.comCervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia ConferenceOctober 29, 2024 | globenewswire.comCervoMed Inc. (CRVO)October 20, 2024 | finance.yahoo.comCervoMed Ends $20 Million Stock Sales Agreement with BTIGOctober 4, 2024 | finance.yahoo.comCervoMed to Participate in 3rd Annual ROTH Healthcare Opportunities ConferenceOctober 2, 2024 | globenewswire.comCervoMed to Deliver Late-Breaking Oral Presentations at the 17th Clinical Trials on Alzheimer's Disease Conference (CTAD)September 27, 2024 | tmcnet.comArmistice Capital LLC Cuts Holdings in CervoMed Inc. (NASDAQ:CRVO)Armistice Capital LLC trimmed its holdings in shares of CervoMed Inc. (NASDAQ:CRVO - Free Report) by 12.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 640,000 shares of the company's stock after selling 94,36September 26, 2024 | marketbeat.comCervoMed Inc. Forecasted to Earn FY2024 Earnings of ($1.34) Per Share (NASDAQ:CRVO)CervoMed Inc. (NASDAQ:CRVO - Free Report) - Research analysts at Chardan Capital issued their FY2024 earnings estimates for shares of CervoMed in a report released on Wednesday, September 18th. Chardan Capital analyst D. Gataulin anticipates that the company will post earnings of ($1.34) per sharSeptember 23, 2024 | marketbeat.comWith 35% ownership, insiders at CervoMed Inc. (NASDAQ:CRVO) are pretty optimistic and have been buying recentlySeptember 21, 2024 | finance.yahoo.comChardan Capital Initiates Coverage of CervoMed (CRVO) with Buy RecommendationSeptember 19, 2024 | msn.comCervoMed (NASDAQ:CRVO) Earns Buy Rating from Analysts at Chardan CapitalChardan Capital began coverage on shares of CervoMed in a report on Wednesday. They issued a "buy" rating and a $55.00 price target for the company.September 18, 2024 | marketbeat.comCervoMed (NASDAQ:CRVO) Trading 1.2% Higher CervoMed (NASDAQ:CRVO) Trading Up 1.2%September 12, 2024 | marketbeat.comCervoMed Inc. (NASDAQ:CRVO) Short Interest Up 46.2% in AugustCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,010,000 shares, an increase of 46.2% from the July 31st total of 690,700 shares. Currently, 18.9% of the shares of the stock are short sold. Based on an average daily trading volume, of 78,600 shares, the days-to-cover ratio is presently 12.8 days.August 31, 2024 | marketbeat.comCervoMed to Participate in Upcoming Investor ConferencesAugust 27, 2024 | globenewswire.comCervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy BodiesAugust 22, 2024 | globenewswire.comCervoMed Inc. (NASDAQ:CRVO) Sees Significant Increase in Short InterestCervoMed Inc. (NASDAQ:CRVO - Get Free Report) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 690,700 shares, an increase of 14.8% from the July 15th total of 601,700 shares. Currently, 12.9% of the shares of the company are short sold. Based on an average trading volume of 70,300 shares, the short-interest ratio is presently 9.8 days.August 18, 2024 | marketbeat.comFY2024 Earnings Forecast for CervoMed Inc. (NASDAQ:CRVO) Issued By Brookline Capital ManagementCervoMed Inc. (NASDAQ:CRVO - Free Report) - Research analysts at Brookline Capital Management boosted their FY2024 earnings estimates for CervoMed in a research report issued on Monday, August 12th. Brookline Capital Management analyst T. Bussian now expects that the company will post earnings peAugust 15, 2024 | marketbeat.comCervoMed (NASDAQ:CRVO) Issues Quarterly Earnings Results, Misses Estimates By $0.03 EPSCervoMed (NASDAQ:CRVO - Get Free Report) issued its earnings results on Monday. The company reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of ($0.24) by ($0.03). The business had revenue of $3.29 million during the quarter, compared to analyst estimates of $3.48 million. CervoMed had a negative net margin of 38.30% and a negative return on equity of 58.63%.August 13, 2024 | marketbeat.comCervoMed Inc.: CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 13, 2024 | finanznachrichten.deCervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate UpdatesAugust 12, 2024 | finance.yahoo.comMorgan Stanley Predicts up to ~230% Surge for These 2 ‘Strong Buy’ StocksAugust 5, 2024 | msn.comCervoMed to Participate in The Canaccord Genuity 44th Annual Growth ConferenceJuly 30, 2024 | globenewswire.comMorgan Stanley Initiates Coverage of CervoMed (CRVO) with Overweight RecommendationJuly 27, 2024 | msn.comMorgan Stanley starts CervoMed at overweight, cites upcoming dataJuly 26, 2024 | msn.comAnalysts Offer Insights on Healthcare Companies: CervoMed (CRVO) and Edwards Lifesciences (EW)July 25, 2024 | markets.businessinsider.comDP8.SG,0P0001BU47,0 (DP8.SG)July 25, 2024 | uk.finance.yahoo.comCervoMed's (CRVO) "Buy" Rating Reiterated at Canaccord Genuity GroupCanaccord Genuity Group reissued a "buy" rating and issued a $65.00 price objective on shares of CervoMed in a report on Thursday.July 25, 2024 | marketbeat.comBuy Rating for CervoMed Amid Strong Potential of Neflamapimod in DLB TreatmentJuly 19, 2024 | markets.businessinsider.comCervoMed to Participate in the Emerging Growth ConferenceJuly 17, 2024 | globenewswire.comShort Interest in CervoMed Inc. (NASDAQ:CRVO) Rises By 92.8%CervoMed Inc. (NASDAQ:CRVO - Get Free Report) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 350,700 shares, an increase of 92.8% from the June 15th total of 181,900 shares. Based on an average daily trading volume, of 50,000 shares, the short-interest ratio is currently 7.0 days. Currently, 6.6% of the shares of the company are short sold.July 12, 2024 | marketbeat.comCervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024July 11, 2024 | globenewswire.comCRVO Stock Earnings: CervoMed Misses EPS, Beats Revenue for Q4 2023July 10, 2024 | investorplace.comCervoMed Inc. (NASDAQ:CRVO) Forecasted to Earn Q2 2024 Earnings of ($0.42) Per ShareCervoMed Inc. (NASDAQ:CRVO - Free Report) - Investment analysts at Brookline Capital Management issued their Q2 2024 earnings estimates for shares of CervoMed in a research report issued on Monday, July 8th. Brookline Capital Management analyst T. Bussian anticipates that the company will post eaJuly 10, 2024 | marketbeat.comCervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy BodiesJune 11, 2024 | globenewswire.comCervoMed’s Buy Rating Backed by First-Mover Advantage in DLB Treatment and Positive Trial ProspectsMay 29, 2024 | markets.businessinsider.comCervoMed Inc. (NASDAQ:CRVO) Sees Significant Growth in Short InterestCervoMed Inc. (NASDAQ:CRVO - Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 126,500 shares, a growth of 144.2% from the April 30th total of 51,800 shares. Currently, 2.4% of the company's stock are sold short. Based on an average daily volume of 24,600 shares, the short-interest ratio is presently 5.1 days.May 28, 2024 | marketbeat.comCervoMed Appoints William Elder To Succeed William Tanner As CFOMay 20, 2024 | markets.businessinsider.com Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this if you missed cheap Bitcoin (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Because a new blockchain is taking the world by storm… It’s seeing rapid adoption amongst crypto fans… And just now starting to break into the mainstream. While I cannot promise future returns or against losses… This might not just be another chance at Bitcoin-like gains… It could be EVEN bigger. But this market is moving fast… So if you want a shot at getting in on what could be the ground floor Click Here for Details. CRVO Media Mentions By Week CRVO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRVO News Sentiment▼-0.120.56▲Average Medical News Sentiment CRVO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRVO Articles This Week▼132▲CRVO Articles Average Week Get CervoMed News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADCT News PRQR News ZURA News TSHA News TCRX News ACIU News AVIR News BTMD News PSTX News URGN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRVO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CervoMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CervoMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRVO Stock Alerts